Developing, funding and conducting clinical trials in immune tolerance
An NIH-sponsored clinical trial for people with primary membranous nephropathy
REBOOT is currently enrolling participants in Part B
If you are between the ages of 18-75 and have been diagnosed with primary membranous nephropathy, you may be eligible to participate.
Learn more ›
Find a REBOOT clinical research center near you.
A clinical trial evaluating belimumab with rituximab for primary membranous nephropathy.